Chondrosarcoma, Mesenchymal
Showing 1 - 25 of 1,414
Clear Cell Chondrosarcoma, Dedifferentiated Chondrosarcoma, Locally Advanced Chondrosarcoma Trial in France (Laboratory
Active, not recruiting
- Clear Cell Chondrosarcoma
- +6 more
- Laboratory Biomarker Analysis
- +2 more
-
Bordeaux, France
- +5 more
Sep 20, 2022
Conventional Chondrosarcoma, Myxoid Liposarcoma, Mesenchymal Chondrosarcoma Trial in Netherlands, Spain (sirolimus and
Completed
- Conventional Chondrosarcoma
- +3 more
- sirolimus and cyclophosphamide
-
Leiden, Netherlands
- +6 more
Apr 19, 2022
Osteosarcoma, Bone Tumor, Bone Sarcoma Trial
Not yet recruiting
- Osteosarcoma
- +25 more
- (no location specified)
Aug 24, 2022
Mesenchymal Chondrosarcoma Trial in Italy (Trabectedin)
Active, not recruiting
- Mesenchymal Chondrosarcoma
-
Prato, Firenze, Italy
- +5 more
Oct 29, 2021
Engagement Trends in Chondrosarcoma Clinical Trials
Not yet recruiting
- Chondrosarcoma
-
San Francisco, CaliforniaPower Life Sciences
Sep 1, 2023
Chordoma, Chondrosarcoma Trial in Madrid (5-fraction hipofractionated protontheray)
Recruiting
- Chordoma
- Chondrosarcoma
- 5-fraction hipofractionated protontheray
-
Madrid, SpainCentro de Protonterapia Quironsalud
May 15, 2023
Bone Sarcoma, Osteosarcoma, Ewing Sarcoma Trial in France (Treatment by Regorafenib, Treatment by Placebo)
Recruiting
- Bone Sarcoma
- +6 more
- Treatment by Regorafenib
- Treatment by Placebo
-
Besançon, France
- +15 more
Aug 18, 2022
Locally Advanced Unresectable Primary Central Chondrosarcoma, Metastatic Primary Central Chondrosarcoma, Unresectable Primary
Suspended
- Locally Advanced Unresectable Primary Central Chondrosarcoma
- +2 more
- Belinostat
- +5 more
-
Phoenix, Arizona
- +38 more
Feb 2, 2023
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1
Not yet recruiting
- Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
- Ivosidenib 500mg
- Placebo
- (no location specified)
Nov 7, 2023
Sarcoma, Sarcoma,Soft Tissue, Sarcoma of Bone Trial in Shanghai (Camrelizumab and fluzoparib with concurrent stereotactic body
Recruiting
- Sarcoma
- +2 more
- Camrelizumab and fluzoparib with concurrent stereotactic body radiotherapy (SBRT)
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University, School of Medici
Oct 3, 2023
Periosteal Chondrosarcoma: a Single Institution Experience
Completed
- Periosteal Chondrosarcoma
-
Bologna, ItalyIRCCS- Istituto Ortopedico Rizzoli
Aug 22, 2022
Chondrosarcoma Trial (Anlotinib HCl, PD-1 inhibitor)
Not yet recruiting
- Chondrosarcoma
- Anlotinib hydrochloride
- PD-1 inhibitor
- (no location specified)
Dec 31, 2021
Chondrosarcoma Trial in Houston (Proton Beam Therapy)
Active, not recruiting
- Chondrosarcoma
- Proton Beam Therapy
-
Houston, TexasMD Anderson Cancer Center
Aug 25, 2022
AIDS Virus, Disorder of Immune Reconstitution Trial in Jinan (normal saline, Mesenchymal stem cells)
Recruiting
- AIDS Virus
- Disorder of Immune Reconstitution
- normal saline
- Mesenchymal stem cells
-
Jinan, Shandong, ChinaShandong Public Health Clinical Center
May 14, 2023
Chondrosarcoma Trial in Iowa City (Zoledronic Acid)
Recruiting
- Chondrosarcoma
- Zoledronic Acid
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Mar 16, 2022
Periodontitis Trial in Beijing (Human Dental Fulp Stem Cells)
Not yet recruiting
- Periodontitis
- Human Dental Fulp Stem Cells
-
Beijing, Beijng, ChinaPeking University Third Hospital
Jun 20, 2023
Osteoarthritis, Knee Trial (Human Umbilical Mesenchymal Stem Cells)
Not yet recruiting
- Osteoarthritis, Knee
- Human Umbilical Mesenchymal Stem Cells
- (no location specified)
Oct 8, 2023
Dermal Regeneration Trial in Lahore (Autologous Mesenchymal stem cells injection, Homogenized fat injection)
Recruiting
- Dermal Regeneration
- Autologous Mesenchymal stem cells injection
- Homogenized fat injection
-
Lahore, Punjab, PakistanKing Edward Medical University
Nov 17, 2023
Decompensated Cirrhosis Trial in Beijing (Human Umbilical Cord-derived Mesenchymal Stem Cells)
Not yet recruiting
- Decompensated Cirrhosis
- Human Umbilical Cord-derived Mesenchymal Stem Cells
-
Beijing, ChinaBeijing 302 Hospital
Aug 2, 2023
Knee Osteoarthritis Trial in Shanghai, Beijing, Hangzhou (Mesenchymal progenitor cells, Sodium Hyaluronate Injection)
Not yet recruiting
- Knee Osteoarthritis
- Mesenchymal progenitor cells
- Sodium Hyaluronate Injection
-
Shanghai, Shanghai, China
- +5 more
Aug 9, 2023
Lupus Erythematosus Trial in Surakarta (Secretome, Placebo)
Completed
- Lupus Erythematosus
- Secretome
- Placebo
-
Surakarta, Middle Java, IndonesiaMoewardi General Hospital
Jun 25, 2023
Rheumatoid Arthritis Trial in Surakarta (Messenchymal stem cell secretome, Placebo)
Completed
- Rheumatoid Arthritis
- Messenchymal stem cell secretome
- Placebo
-
Surakarta, Middle Java, IndonesiaMoewardi General Hospital
Jun 26, 2023
Long Non-coding RNA in Process of Epithelial-mesenchymal
Active, not recruiting
- Periodontal Disease, AVDC Stage 3and 4
- +2 more
- periodontitis challenge
-
Baghdad, Iraqsaif mohammed T AL Mufti
Aug 8, 2023
Cardiovascular Diseases Trial in Nassau (Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte))
Recruiting
- Cardiovascular Diseases
- Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
-
Nassau, The Bahamas, BahamasThe Partners Clinical Research Centre at The Medical Pavilion
Oct 17, 2023